More data from the ‘Blue Rockers’

BlueRock Therapeutics has published two preclinical research reports outlining the cell culturing method that they are taking into clinical trials.

News Research news

Parkinson’s and pesticides

Much of our focus is on treatments, but treatments are only part of the story. A vital step for Cure Parkinson’s is to stop people from getting Parkinson’s in the first place. Read more about taking action against pesticide use.

News Research news

GDNF – A new chapter

We welcome the news of further investment in GDNF (Glial Cell-Line Derived Neurotrophic Factor) by Parkinson’s UK.

News Research news

Is Inhibikase ‘Abl’ to beat nilotinib?

Inhibikase Therapeutics has designed a novel drug that is similar to the drug nilotinib – previously tested in people with Parkinson’s – but is better at reaching its target in the brain.

News Research news

Ambroxol – new real-world data

Ambroxol is a cough medication that Cure Parkinson’s is repurposing for potential use in treating Parkinson’s, and recently published data provides further support for this pioneering new study.